{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:52:15Z","timestamp":1789887135812,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.dsx.2018.07.003","type":"journal-article","created":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T16:50:32Z","timestamp":1531846232000},"page":"3053-3056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["The potential of transdermal nitric oxide treatment for diabetic peripheral neuropathy and diabetic foot ulcers"],"prefix":"10.1016","volume":"13","author":[{"given":"David M.","family":"Walton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Minton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alonzo D.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2018.07.003_bib1","series-title":"More than 29 million Americans have diabetes; 1 in 4 doesn\u2019t know","author":"CDC","year":"2014"},{"key":"10.1016\/j.dsx.2018.07.003_bib2","series-title":"Nerve damage (diabetic neuropathies)","author":"NIH","year":"2013"},{"issue":"6","key":"10.1016\/j.dsx.2018.07.003_bib3","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.2337\/diacare.26.6.1790","article-title":"The health care costs of diabetic peripheral neuropathy in the US","volume":"26","author":"Gordois","year":"2003","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.dsx.2018.07.003_bib4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2337\/dc12-2625","article-title":"Economic costs of diabetes in the U.S. in 2012","volume":"36","author":"American Diabetes A","year":"2013","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.dsx.2018.07.003_bib5","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2018.07.003_bib6","series-title":"Number of Americans with diabetes projected to double or triple by 2050","author":"CDC","year":"2010"},{"issue":"3","key":"10.1016\/j.dsx.2018.07.003_bib7","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2337\/dc13-2176","article-title":"Burden of diabetic foot ulcers for medicare and private insurers","volume":"37","author":"Rice","year":"2014","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.dsx.2018.07.003_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/diaclin.23.1.9","article-title":"Management of diabetic peripheral neuropathy","volume":"23","author":"Boulton","year":"2005","journal-title":"Clin Diabetes"},{"issue":"20","key":"10.1016\/j.dsx.2018.07.003_bib9","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1212\/WNL.0000000000003882","article-title":"Pharmacotherapy for diabetic peripheral neuropathy pain and quality of life: a systematic review","volume":"88","author":"Waldfogel","year":"2017","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.dsx.2018.07.003_bib10","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1111\/dme.13083","article-title":"Systematic review of treatments for diabetic peripheral neuropathy","volume":"33","author":"Cakici","year":"2016","journal-title":"Diabet Med"},{"issue":"8","key":"10.1016\/j.dsx.2018.07.003_bib11","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1089\/jpm.2012.9571","article-title":"Topical capsaicin for neuropathic pain #255","volume":"15","author":"Groninger","year":"2012","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.dsx.2018.07.003_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010958","article-title":"Topical lidocaine for neuropathic pain in adults","volume":"7","author":"Derry","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dsx.2018.07.003_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011003","article-title":"Desipramine for neuropathic pain in adults","volume":"9","author":"Hearn","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dsx.2018.07.003_bib14","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","volume":"1","author":"Lunn","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dsx.2018.07.003_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/TCRM.S32193","article-title":"Tapentadol extended release in the management of peripheral diabetic neuropathic pain","volume":"11","author":"Vadivelu","year":"2015","journal-title":"Therapeut Clin Risk Manag"},{"issue":"10","key":"10.1016\/j.dsx.2018.07.003_bib16","first-page":"1999","article-title":"Treatment of neuropathic pain with venlafaxine: a systematic review","volume":"18","author":"Aiyer","year":"2017","journal-title":"Pain Med"},{"issue":"9","key":"10.1016\/j.dsx.2018.07.003_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/toxins9090260","article-title":"Botulinum toxin for the treatment of neuropathic pain","volume":"9","author":"Park","year":"2017","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.dsx.2018.07.003_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4239\/wjd.v6.i1.37","article-title":"Literature review on the management of diabetic foot ulcer","volume":"6","author":"Yazdanpanah","year":"2015","journal-title":"World J Diabetes"},{"issue":"2","key":"10.1016\/j.dsx.2018.07.003_bib19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diacare.26.2.491","article-title":"Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology","volume":"26","author":"Moulik","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2018.07.003_bib20","unstructured":"Skinsight Neurogenic Ulcer (Diabetic Ulcer); https:\/\/www.skinsight.com\/skin-conditions\/adult\/neurogenic-ulcer-diabetic-ulcer. Accessed 19 February 2018."},{"issue":"3","key":"10.1016\/j.dsx.2018.07.003_bib21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2337\/diabetes.47.3.457","article-title":"Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration","volume":"47","author":"Veves","year":"1998","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.dsx.2018.07.003_bib22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/CIRCULATIONAHA.104.511964","article-title":"Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy","volume":"112","author":"Ii","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2018.07.003_bib23","doi-asserted-by":"crossref","unstructured":"Schindelin JA-C I. & Frise, E. et\u00a0al. Fiji: an open-source platform for biological-image analysis. Nat Methods.9(7): 676\u2013682.","DOI":"10.1038\/nmeth.2019"},{"issue":"7","key":"10.1016\/j.dsx.2018.07.003_bib24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2017","journal-title":"Nat Methods"},{"issue":"3","key":"10.1016\/j.dsx.2018.07.003_bib25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0022034509359125","article-title":"Factors affecting wound healing","volume":"89","author":"Guo","year":"2010","journal-title":"J\u00a0Dent Res"},{"issue":"2","key":"10.1016\/j.dsx.2018.07.003_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.33549\/physiolres.930718","article-title":"Spontaneous quantal and non-quantal release of acetylcholine at mouse endplate during onset of hypoxia","volume":"54","author":"Bukharaeva","year":"2005","journal-title":"Physiol Res"},{"key":"10.1016\/j.dsx.2018.07.003_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1113\/jphysiol.1986.sp016010","article-title":"Factors influencing an increase in spontaneous transmitter release by hypoxia at the mouse neuromuscular junction","volume":"372","author":"Nishimura","year":"1986","journal-title":"J\u00a0Physiol (London)"},{"issue":"13","key":"10.1016\/j.dsx.2018.07.003_bib28","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/CIRCULATIONAHA.105.602532","article-title":"Endothelial nitric oxide synthase in vascular disease: from marvel to menace","volume":"113","author":"Forstermann","year":"2006","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.dsx.2018.07.003_bib29","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2337\/diacare.25.10.1699","article-title":"Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray: a double-blind placebo-controlled cross-over study","volume":"25","author":"Yuen","year":"2002","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.dsx.2018.07.003_bib30","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.2337\/dc10-2150","article-title":"Peripheral vascular disease and peripheral neuropathy in individuals with cardiometabolic clustering and obesity: national Health and Nutrition Examination Survey 2001-2004","volume":"34","author":"Ylitalo","year":"2011","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.dsx.2018.07.003_bib32","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","article-title":"Diabetic neuropathy: clinical manifestations and current treatments","volume":"11","author":"Callaghan","year":"2012","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.dsx.2018.07.003_bib33","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1172\/JCI0214995","article-title":"Evidence for in\u00a0vivo transport of bioactive nitric oxide in human plasma","volume":"109","author":"Rassaf","year":"2002","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.dsx.2018.07.003_bib34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000047649","article-title":"The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke","volume":"11","author":"Bath","year":"2001","journal-title":"Cerebrovasc Dis"}],"updated-by":[{"DOI":"10.1016\/j.dsx.2020.12.010","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000}}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118302704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118302704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T19:44:52Z","timestamp":1661629492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402118302704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1871402118302704"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2018.07.003","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.dsx.2020.12.010","asserted-by":"object"}]},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential of transdermal nitric oxide treatment for diabetic peripheral neuropathy and diabetic foot ulcers","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2018.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}